Consolidated statement of stockholders equity (deficiency) (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Deficit During Exploration Stage [Member]	Total
Beginning Balance at Feb. 28, 2014	$ 35,032,933	$ 16,922,064	$ (13,514,818)	$ (43,871,806)	$ (5,431,627)
Beginning Balance (Shares) at Feb. 28, 2014	105,651,157
Net Loss				(1,653,557)	(1,653,557)
Rounding upon stock split (Shares)	140
Shares issued for convertible debentures exercised	460,748				460,748
Shares issued for convertible debentures exercised (Shares)	3,839,562
Amount allocated to share purchase warrants on re-issuance of debenture		75,953			75,953
Amount allocated to beneficial conversion feature on re- issuance of debenture		75,953			75,953
Accretion of discount for future periods on exercised convertible debentures	58,052				58,052
Accretion of beneficial conversion feature for future periods on exercised convertible debentures	18,055				18,055
Ending Balance at May. 31, 2014	$ 35,569,788	$ 17,073,970	$ (13,514,818)	$ (45,525,363)	$ (6,396,423)
Ending Balance (Shares) at May. 31, 2014	109,490,859